IL10 and heart failure: We have previously demonstrated that pre‐treatment with the CpG ODN 1668 16 hours before induction of I/R in mice could effectively reduce the size of the resulting infarct as well as rates of functional cardiac failure.12 Heightened up‐regulation of IL‐10 is supposed to be one key factor.